News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,636 Results
Type
Article (5044)
Company Profile (17)
Press Release (220575)
Section
Business (82298)
Career Advice (461)
Deals (15055)
Drug Delivery (10)
Drug Development (19073)
Employer Resources (30)
FDA (3681)
Job Trends (3909)
News (120237)
Policy (7522)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (293)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14789)
ALS (20)
Alzheimer's disease (250)
Antibody-drug conjugate (ADC) (11)
Approvals (3699)
Artificial intelligence (42)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2869)
Biosimilars (17)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (452)
Cardiovascular disease (24)
Career advice (393)
Career pathing (3)
CAR-T (32)
Cell therapy (106)
Cervical cancer (2)
Clinical research (16041)
Collaboration (172)
Compensation (170)
Complete response letters (2)
COVID-19 (302)
CRISPR (8)
C-suite (108)
Cystic fibrosis (16)
Data (525)
Depression (6)
Diabetes (46)
Diagnostics (2045)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (14)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40890)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37834)
Executive appointments (313)
FDA (3935)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (187)
Gene editing (16)
Generative AI (2)
Gene therapy (53)
GLP-1 (109)
Government (420)
Guidances (17)
Healthcare (5068)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (14)
Indications (6)
Infectious disease (318)
Inflammatory bowel disease (26)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7828)
IRA (3)
Job creations (1123)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2342)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (52)
MASH (28)
Medical device (3878)
Medtech (3879)
Mergers & acquisitions (7434)
Metabolic disorders (126)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (347)
NextGen: Class of 2025 (1680)
Non-profit (734)
Northern California (941)
Now hiring (3)
Obesity (55)
Opinion (30)
Ovarian cancer (17)
Pain (13)
Pancreatic cancer (14)
Parkinson's disease (28)
Partnered (4)
Patents (22)
Patient recruitment (31)
Peanut (5)
People (24650)
Pharmaceutical (5)
Pharmacy benefit managers (10)
Phase I (4784)
Phase II (6965)
Phase III (5554)
Pipeline (565)
Policy (9)
Postmarket research (625)
Preclinical (1874)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1878)
Recruiting (8)
Regulatory (5123)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (4)
Schizophrenia (21)
Series A (28)
Series B (24)
Sickle cell disease (7)
Southern California (711)
Special edition (2)
Spinal muscular atrophy (29)
Sponsored (4)
Startups (1008)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
United States (7146)
Vaccines (36)
Venture capitalists (2)
Weight loss (23)
Women's health (1)
Date
Today (65)
Last 7 days (222)
Last 30 days (735)
Last 365 days (9979)
2025 (3132)
2024 (11054)
2023 (13216)
2022 (18674)
2021 (19707)
2020 (18267)
2019 (13266)
2018 (10238)
2017 (10009)
2016 (9161)
2015 (12129)
2014 (9593)
2013 (7708)
2012 (8332)
2011 (8802)
2010 (8636)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11466)
Australia (1610)
California (1971)
Canada (710)
China (73)
Colorado (84)
Connecticut (97)
Delaware (30)
Europe (24546)
Florida (282)
Georgia (34)
Idaho (23)
Illinois (113)
India (7)
Indiana (64)
Iowa (2)
Japan (72)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1581)
Michigan (85)
Minnesota (140)
Mississippi (1)
Missouri (24)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (571)
New Mexico (5)
New York (478)
North Carolina (331)
North Dakota (3)
Northern California (941)
Ohio (59)
Oklahoma (5)
Oregon (4)
Pennsylvania (350)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (711)
Tennessee (40)
Texas (229)
Utah (62)
Virginia (46)
Washington D.C. (9)
Washington State (175)
West Virginia (2)
Wisconsin (24)
225,636 Results for "cigna corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
April 1, 2025
·
4 min read
Pharmacy benefit managers
Cigna to Remove AbbVie’s Humira From Formularies, Putting More Pressure on Blockbuster
Mirroring fellow pharmacy benefit manager CVS Caremark, Cigna’s Express Scripts is taking Humira off its major commercial formularies starting next year and focusing on more affordable biosimilar options.
August 27, 2024
·
2 min read
·
Tristan Manalac
Business
The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook
Global health company The Cigna Group reported strong first quarter 2024 results reflecting growth across its diversified portfolio of businesses.
May 2, 2024
·
26 min read
BioMidwest
Cigna and EviCore Add Positive Coverage for the Evoke® System
Saluda Medical, Inc. announced that key US commercial payers, including Cigna and EviCore, have updated their policies to include coverage for the use of the Evoke® closed-loop spinal cord stimulation System.
April 10, 2024
·
2 min read
Pharm Country
The Cigna Group to Host Investor Day in New York City on March 7
Global health company The Cigna Group (NYSE:CI) will be hosting its Investor Day on Thursday, March 7, 2024 in New York City.
January 31, 2024
·
1 min read
Deals
The Cigna Group Announces Commencement of Tender Offers for up to $2.25 Billion in Aggregate Principal Amount of Outstanding Notes
The Cigna Group Announces Commencement of Tender Offers for up to $2.25 Billion in Aggregate Principal Amount of Outstanding Notes.
February 5, 2024
·
12 min read
Drug Delivery
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost
Starting in June 2024, Evernorth Health Services will offer Humira biosimilar products with no out-of-pocket cost through its Accredo specialty pharmacy.
April 26, 2024
·
2 min read
·
Tristan Manalac
Pharmacy benefit managers
Cigna Continues Biosimilar Push, Targets J&J’s Stelara With No Out-of-Pocket Cost
Thursday’s announcement comes after the insurance giant last week said it would remove AbbVie’s Humira from its major formularies starting in 2025, replacing the blockbuster with more affordable biosimilars.
September 6, 2024
·
2 min read
·
Tristan Manalac
Pharm Country
The Cigna Group Announces Appearance at the 42nd Annual J.P. Morgan Healthcare Conference
Global health company The Cigna Group (NYSE:CI) announced today that David Cordani, chairman and chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024 in San Francisco, CA.
December 19, 2023
·
1 min read
Business
Cigna Corporation’s Fourth Quarter 2022 Earnings Release Details
Global health services company Cigna Corporation (NYSE:CI) will release its fourth quarter 2022 financial results on Friday, February 3, 2023, and will host a conference call the same day.
January 12, 2023
·
2 min read
1 of 22,564
Next
